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ABSTRACT 
Objective: The objective of the study was to investigate the memory improving activity of Triphala Churna hydro-methanolic fruit extract on 
learning and memory functions in Streptozotocin (I. C. V) induced dementia in rats by using morris water maze and elevated plus maze.  
Methods: A total of 42 albino wistar rats weighing 80-100 g were randomized into 7 equal groups as follows: Normal control group received 
normal saline (1 ml/kg p. o.) for 24 d, STZ treated group (3 mg/kg, i. c. v) were administered in two dosage regimen i.e. on first day and third day.), 
Standard group: Streptozotocin (3 mg/kg i. c. v)+Vitamin E (100 mg/kg/day p. o.) were administered for 21 d, Standard group: Streptozotocin (3 
mg/kg i. c. v)+Rivastigmine (2 mg/kg/day p. o.) were administered for 21 d. The learning and memory-impaired rats were treated with Triphala 
Churna Formulation 1, Triphala Churna Formulation 2 and Triphala Churna Formulation 3 for 21 d (100 mg/kg p. o.). AchE activity, lipid 
peroxidation, superoxide dismutase, glutathione level of brain homogenate was estimated in Control/STZ (I. C. V)/Standard/Triphala Churna fruits 
extract treated rats. 
Results: Administration of Triphala Churna fruits extract significantly restored learning and memory impairment induced by STZ (I. C. V) in the 
elevated plus maze and morris water maze. Furthermore, in the TPLC F2 and TPLC F3 treated group brain AchE level was decreased (P≤0.01) as 
well as brain lipid peroxidation was also decreased (P≤0.001). Brain antioxidant enzymes such as glutathione level were increased (P≤0.001) in the 
TPLC1 and TPLC2 treated group when compared to the STZ treated group, TPLC F2 and TPLC F3 treated group showed significant (P≤0.001, 
P≤0.01) increase in superoxide dismutase level.  
Conclusion: Triphala Churna fruits extract has an improving effect on learning and memory impairment rats produced by Streptozotocin (I. C. V) 
and may have a useful effect in the treatment of dementia and Alzheimer's disease. 
Keywords: Triphala Churna, AchE, Vitamin E, Rivastigmine, Streptozotocin (I. C. V.) and antioxidant 




Acquisition of information and skill is defined as learning [1]. 
Through two processes behaviour is modified by experience–one is 
learning which means the acquisition of new knowledge about the 
environment and another is a memory which means its retention 
[2]. Dementia is a brain disorder denoted by a decrease in several 
higher mental functions such as memory, intellect, a personality that 
occurs serious impairments in daily life [3]. The prevalence of 
dementia increases with age, doubling every 5 y between the ages of 
60 and 90 [4]. Dementia is induced by a disease that impairs tissues 
in the brain causing the destruction of brain functioning. Dementia is 
characterized by irreversible and reversible causes. Dementia due to 
long-term substance abuse, accumulation of blood beneath the outer 
covering of the brain that result of head injury, subdural hematoma, 
normal pressure hydrocephalus, toxic reactions like excessive 
alcohol or drug use, hypothyroidism, and nutritional deficiencies like 
vitamin B12 and folate deficiencies. Some of the irreversible and 
non-treatable cause of dementia involves diseases that cause 
degradation or loss of nerve cells in the brain such as PD, AD [4, 5] 
and HD, multi-infracts dementia (dementia because of multiple small 
strokes, also known as vascular dementia), infections that affect the 
spinal cord and brain, for example acquired-immune deficiency 
syndrome (AIDS) dementia complex and Creutzfeldt-Jakob disease. 
Some people have a combined type of dementia including both 
vascular dementia and AD. The most common symptoms that are 
mainly associated with dementia are psychosis, delirium from a 
sudden medical problem, aggression, insomnia or ―sundowning 
(confusion in the early evening or late afternoon), anger, anxiety, pain 
from arthritis and depression [4, 6]. It represents a decrease in the 
previous level of functioning and it is also associated with impairment 
in psychiatric disturbances, behavioural and functional abilities [7, 8]. 
Intracerebroventricular (ICV) administration of streptozotocin (STZ) 
in rats is frequently employed to study experimental dementia by 
understanding some of the pathological aspects of SAD in humans, 
currently, [26]. Moreover, it has been well expressed that ICV-STZ 
rat model is targeting the functioning of brain IR signalling cascade. 
Decreased levels of glucose/energy metabolism especially in 
cerebral cortex and hippocampus areas in the brain have been 
investigated starting from 3 w following ICV-STZ administration and 
hence mitochondrial dysfunction [14]. Further, a progressive trend 
towards oxidative stress has also been obtained starting as early as 
1 w following the ICV-STZ administration [27]. In addition to 
decreased energy metabolism and mitochondrial dysfunction, 
increased free radical generation, subsequent oxidative as well as 
nitrosative stress which are well revealed to impair learning and 
memory leading to cognitive dysfunction [28]. 
In ayurveda, triphala is well known as polyherbal formulation. In 
Indian system of medicine, it is used as a rasnayana drug [9]. 
Triphala is consists of the three dried fruits of trees and they are 
Indian gooseberry (Emblica officinalis Gaertn, family Euphobiaceae), 
Belleric myrobalan (Terminalia belericaLinn. Family, Combretaceae) 
and Chebulic myrobalan (Terminalia chebula Retzr. Family 
Combretaceae) [10, 11]. It is composed equal proportion (1:1:1) of 
these three fruits as described in ayurvedic formulary of india. 
Triphala is termed as tridosic rasnayana in ayurveda and it is having 
rejuvenating and balancing effect on three constitutional elements 
which regulate the human life (vata, pitta and kapha)[9]. The most 
commonly found polyphenolic compounds in the plant extracts are 
phenolic acids, flavonoids and tannins. 70 % Methanolic extract of 
triphala exhibit antioxidative properties by the following order T. 
Chebula ˃ E. Officinalis ˃T. Bellerica. In their flavonoid content, the 
same order is followed, while in case of phenolic content the order is 
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E. officinalis>T. belerica>T. chebula [12]. The aim of my study was a 
pharmacological evaluation of Triphala churna in streptozotocin (i. 
c. v.) induced dementia in rats. 
MATERIALS AND METHODS 
Chemicals and reagents 
Acetic acid, Acetylthiocholine iodide, Bovine serum albumin, Calcium 
chloride, Chloral hydrate, Copper sulfate solution, Dextrose, 
Ethylene diamine tetra acetic acid (EDTA), Folin-ciocalteau reagent 
solution, Hydro-xylamine hydrochloride, Magnesium Chloride, 
Methanol, Nitro blue tetrazolium (NBT), Potassium chloride, 
Potassium phosphate dibasic, Protein estimation kit, Reduced 
glutathione, Streptozotocin(STZ), Sodium chloride (Nacl), Sodium 
potassium tartrate, Sodium hydroxide, Sodium dihydrogen 
phosphate, Sodium Carbonate, Sodium citrate, Superoxide dismutase 
colorimetric assay kit, Thiobarbituric acid (TBA), Trichloroacetic 
acid (TCA), Triton X-100 were purchased from Central drug house 
(P) Ltd New Delhi. Diethyl ether was purchased from SGRRITS; 
Vitamin E was purchased from Merck Limited, Goa; Rivastigmine 
was purchased from Sun Pharma Laboratories LTD, Sikkim. 
Procurement of triphala churna  
Emblica officinalis (Anwala Churna), Terminalia bellerica (Baheda 
Churna), and Terminalia chebula (Harad churna), manufactured at 
Vyas Pharmaceuticals, indore-452015 were obtained from the 
authorized Ayurvedic shop (Krishna Medical Hall, Paltan Bazar), 
local market, Dehradun, Uttarakhand. 
Animals 
Albino wistar rats weighing 80-100 g, were procured from animal 
house facility of Division of pharmaceutical science, Shri Guru Ram 
Rai Institute of Technology and Science, Patel Nagar, Dehradun. The 
care of laboratory animals and all the procedures on animals were 
performed in strict accordance with the CPCSEA, Ministry of forest 
and environment Government of India.  
The protocol was approved by the Institutional Animal Ethics 
Committee (Registration No. 264/PO/ReBi/S/2002/CPCSEA) and 
will be carried out in accordance with the CPCSEA guidelines. 
Experimental protocol 
In present study 7 groups was employed and each group will be 
comprised of 6 animals. 
Group I: Normal control group: Normal saline (1 ml/kg p. o. daily) was 
administered before evaluation of learning and memory for 24 d.  
Group II: Disease induced group: Streptozotocin (3 mg/kg, i. c. v) 
was administered in two dosage regimen i.e. on first day and third 
day.  
Group III: Standard group: Streptozotocin (3 mg/kg i. c. v)+Vitamin 
E (100 mg/kg/day p. o.) was administered for 21 d.  
Group IV: Standard group: Streptozotocin (3 mg/kg i. c. 
v)+Rivastigmine (2 mg/kg/day p. o.) was administered for 21 d.  
Group V: Streptozotocin (3 mg/kg i. c. v)+Triphala Churna 
Formulation 1 (100 mg/kg/day p. o.) was administered for 21 d 
Group VI: Streptozotocin (3 mg/kg i. c. v)+Triphala Churna 
Formulation 2 (100 mg/kg/day p. o.) was administered for 21 d.  
Group VII: Streptozotocin (3 mg/kg i. c. v)+Triphala Churna 
Formulation 3 (100 mg/kg/day p. o.) was administered for 21 d. 
Extraction method 
The powder (100 g) of the individual normal air-dried fruits of T. 
chebula, T. belerica and E. officinalis was stirred using a magnetic 
stirrer with a 7:3 mixture of methanol: water (500 ml) for 15 h; the 
mixture was then centrifuged at 2850 × g and the supernatant 
decanted. The process was repeated by adding the solvent with the 
precipitated pellet. The supernatants were collected, concentrated in 
a rotary evaporator [250-200 mbar at 37 °C] and lyophilized. The 
yields for the plant's materials were 5.2 g, 3.8 g and 4.5 g for T. 
chebula, T. belerica and E. officinalis, respectively. The dried extracts 
were stored at-20 °C until use [12]. 
Three formulations are:  
TPL Churna formulation 1 (T. Chebula: E. Officinalis: T. belerica)=1:1:1  
TPL Churna formulation 2 (T. Chebula: E. Officinalis: T. belerica)=2:1:1  
TPL Churna formulation 3 (T. Chebula: E. Officinalis: T. belerica)=1:2:1  
Streptozotocin (ICV STZ)-induced dementia 
Rats were anaesthetized with anaesthetic ether and I. C. V. injections 
were made with a hypodermic needle of 0.4 mm external diameter 
attached to a 10 μl hamilton microlitre syringe. The needle was cov-
ered with a polypropylene tube except for 3 mm of the tip region so 
as to insert this portion of the needle perpendicularly through the 
skull into the brain of the rats. STZ was dissolved in freshly made 
artificial cerebrospinal fluid ACSF (25 mg/ml) solution. The injection 
site was 1 mm to right or left midpoint on the line drawn through to 
the anterior base of the ears. Injections were performed into the 
right or left ventricle randomly. Two doses of STZ (3 mg/kg) were 
administered by I. C. V. injection bilaterally. The second dose was 
administered 48 h after the first dose. The concentration was 
adjusted so as to deliver a maximum of 5 μl in a single injection [13].  
Preparation of ACSF for STZ 
Artificial Cerebro Spinal Fluid is consists of 147 mmol NaCl; 2.9 
mmol KCl; 1.6 mmol MgCl2; 1.7 mmol CaCl2 and 2.2 mmol dextrose 
[14]. 
Morris water maze 
Acquisition trial 
In this study, spatial learning and memory of animals were tested in 
a morris water maze. The test was performed on day 20-23 and a 
probe trial was performed on day 24. It is comprised of a circular 
water tank (180 cm diameter, 60 cm height) filled with water (25±1 
°C) to a depth of 40 cm. An escape platform (12.5 cm in diameter and 
38 cm high) was put in the pool 2 cm below the surface of the water. 
The escape platform was settled in the middle of one of the 
randomly selected quadrants of the pool and kept in the same 
position throughout the entire experiment. A non-toxic water-
dispersible emulsion (milk) was used to render the water opaque. 
Four equally spaced locations around the edge of the pool (North, 
South, East, and West) were used as start points, which divided the 
pool into 4 quadrants. Without a platform, before the training 
started the rats were allowed to swim freely into the pool for 120s. 
For each trial, each rat was put into the water at one of four starting 
positions, the sequence of which being selected randomly. During 
test trials, rats were placed into the tank at the same starting point, 
with their heads facing the wall and allowed to locate submerged 
platform within 120 sec. The rats received four consecutive daily 
training trials in the following 5 d, with each trial having a ceiling 
time of 120 s and a trial interval of approximately 30s. The rat had to 
swim until it climbed onto the platform submerged underneath the 
water. After climbing onto the platform, the animal remained there for 
30s before the commencement of the next trial. If the rat failed to 
reach the escape platform within the maximally allowed time of 120s, 
it was guided with the help of a rod and allowed to remain on the 
platform for 30s. The time taken by rats to locate the hidden platform 
(latency in seconds) was measured. Animals were subjected to 
training trials for 5 consecutive days, the starting point was changed 
with each exposure as mentioned below and target quadrant (Q4 in 
the present study) remain constant throughout the training period. 
Memory consolidation test 
Twenty four hours after the acquisition phase, a probe test (day 24) 
was performed by removing the platform wherein the extent of 
memory consolidation was assessed. Rats were allowed to swim 
freely in the pool for 120s. The time spent by rats in target quadrant, 
which had previously contained the hidden platform, was noted. The 
time spent by rats in the target quadrant which indicated the degree 
of memory consolidation which had taken place after learning [15, 
16, 5]. 
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Elevated plus maze 
An elevated plus-maze was used to test the cognitive function of 
animals. It is constituted of two opposite open arms (50 cm × 10 cm), 
crossed with two closed arms of the same dimensions with 40 cm high 
walls. The arms were connected by a central square (10 cm × 10 cm) 
and the apparatus was elevated 70 cm from the floor [17]. Memory 
acquisition and retention were tested using elevated plus maze test on 
days 23 and 24. Each rat was placed on the open arm, facing outwards. 
The time taken by the rat to enter the closed arm in the first trial 
(acquisition trial) on 23th day was noted and was called as initial 
transfer latency. Cut-off time was fixed at 90s and in case a rat did not 
move into the closed arm within this period, it was gently pushed into 
one of the closed arms and for 30 s it was allowed to explore the maze. 
The second trial (retention trial) was performed 24 h after the 
acquisition trial and retention transfer latency was noted. The 
retention trial latency was expressed as a percentage of initial trial 
latency [18]. 
Biochemical parameter  
Brain collection and preparation of brain homogenate for 
estimation of AChE activity 
The rats were decapitated by cervical dislocation under light 
anesthesia; brains are removed quickly and placed in ice-cold saline. 
50 mg of tissue was homogenized in 0.1M Phosphate buffer which is 
having pH 8 (5 ml).  
Estimation of acetylcholinesterase (AChE) activity  
The method of AChE activity estimation is popularly known as 
Ellman’s method, developed by George Ellman in 1961. The brain 
cholinesterase activity was estimated by providing an artificial 
chemical, acetylthiocholine (ATC). Thiocholine released because of 
the cleavage of ATC by AChE is allowed to react with 5, 5-dithio-bis-
(2, nitrobenzoic acid) (DTNB), which is reduced to thionitrobenzoic 
acid, a yellow coloured anion with absorption maxima at 412 nm. 
Procedure  
Brains were removed quickly and placed in ice-cold saline. 50 mg of 
tissue was homogenized in 0.1M Phosphate buffer which is having 
pH 8 (5 ml). To a cuvette containing 2.6 ml phosphate buffer (0.1M, 
pH 8), 0.4 ml aliquot of the homogenate is added and 100μl of DTNB. 
Thoroughly the contents of the cuvette were mixed by bubbling air 
and absorbance is measured at 412 nm in a spectrophotometer. 
When absorbance obtains a stable value, it is recorded as the basal 
reading. 20μl of substrate i.e., acetylthiocholine is added and change 
in absorbance is recorded [19, 20]. 
Preparation of Brain homogenate for antioxidant enzyme 
estimation 
Brain tissue samples were homogenized in 0.9% NaCl by using 
tissue homogenizer [21]. 
Estimation of lipid peroxidation 
Lipid peroxidation levels were measured by the Ohkawa et al. 
method. Taken 2 ml of brain homogenate, add 2 ml of 30% of 
trichloroacetic acid after that add 0.8% thiobarbituric acid reagent 
in a test tube. The tubes were covered with aluminium foil and kept 
in shaking water bath for half an hour at 80 °C. After half an hour; 
the tubes were taken out and kept in ice-cold water for half an hour 
Keep test tube in cold water for half an hour. Then process 
homogenate was centrifuged at 3000 RPM for 15 min, the 
supernatant was separated out and absorbance was noted down at 
535 nm against blank [21].  
Estimation of Brain glutathione 
Reduced glutathione estimation was done by the method of Sedlak and 
Lindsay, 1968. To 2 ml of 10% of homogenate, 2.5 ml of 0.02M EDTA 
was added and shaken vigorously. To 2 ml of this mixture, 4 ml of cold 
distilled water and 1 ml of 50% trichloroacetic acid were added and 
was shaken for 10 min. Thereafter, the content was centrifuged at 
3000 x g for 15 min following centrifugation, 2 ml of the supernatant 
was mixed with 0.4M tris buffer (pH 8.9). The whole solution was 
mixed well and 0.1 ml of 0.01M DTNB was added, the absorbance was 
read within 5 min of addition of DTNB at 412 nm against reagent blank 
with no homogenate. For blank reading, the homogenate was 
substituted by 2 ml of distilled water (Sedlak and Lindsay, 1968) [21].  
Estimation of superoxide dismutase  
SOD was estimated according to Kono method 1978. 1.3 ml of 
solution A, 0.5 ml of solution B and 0.1 ml of solution C, 0.1 ml of 
solution D were mixed and rate of NBT reduction was recorded for 
one minute at 560 nm on Schimadzu spectrophotometer UV120-01. 
0.1 ml of the supernatant was added to the test and reference 
cuvettes, which do not contain solution D. Finally, the % inhibition in 
the rate of reduction of NBT was recorded as described above in U/g 
tissue. One enzyme unit was expressed as the inverse of the amount 
of protein (mg) required inhibiting the reduction rate by 50% in one 
minute. The activity was calculated using the % inhibition in a gram 
of tissue and expressed in Unit/g tissue [22, 23]. 
Estimation of total protein 
According to the method of Lowry OH, et al. 1951 total protein was 
done. Total amount of brain total protein was expressed in mg [15]. 
Statistical analysis 
The statistical analysis was carried out using prism graph pad 
7software. All values were represented as mean±SEM. Multiple 
comparisons between different groups was performed using one-
way analysis of variance followed by Tukey’s test for all biochemical 
evaluation except in morris water maze.  
RESULTS 
Pharmacological study  
Behavioral estimation 
Effect of STZ (i. c. v.) on escape latency time (ELT) and time 
spent in target quadrant (TSTQ) on morris water maze in rats 
Control group showed a significant decrease (p≤0.001) in day 4 ELT 
when it was compared to its ELT on day 1(fig. 1). In control group, 
rats spent significantly (p≤0.001) more time in the target quadrant 
(Q4) when it compared to the time spent in other quadrants (Q1, Q2, 
Q3) (fig. 2). STZ treated group showed a significant (p≤0.001) 
increase in ELT when it compared to ELT of the control group (fig. 1) 
on the same day. STZ treated rats also showed significant (p≤0.001) 
decrease in time spent in target quadrant (TSTQ) when it compared 
time spent in target quadrant (Q4) of control group (fig. 2).  
Effect of Triphala Churna fruits extract on escape latency of 
streptozotocin-treated rats in morris water maze (MWM) 
Vitamin E and Rivastigmine treated group significantly (P≤0.001) 
improve the ELT when compared with STZ treated group. TPLC F2 
showed more significant result (P≤0.001) when compared to the STZ 
treated group (fig. 3).  
Effect of Triphala Churna fruits extract on time spent on 
targeted quadrant (TSTQ) of streptozotocin-treated rats in 
morris water maze (MWM) 
When we compared among the Control, STZ, STZ+Vitamin E, 
STZ+Rivastigmine, STZ+TPLC F1, STZ+TPLC F2, STZ+TPLC F3 during 
time spent in targeted quadrant there is a significance difference. 
Administration of Vitamin E and Rivastigmine showed high 
significance at (P≤0.001) when compared with STZ treated group. 
TPLC F1, TPLC F2, TPLC F3 (100 mg/kg p. o.) showed high significance 
at (P≤0.001) when compared with STZ treated group (fig. 4).  
Effect of Triphala Churna fruits extract on transfer latency (TL) 
of streptozotocin-treated rats in elevated plus maze (EPM)  
Treatment with streptozotocin showed significant (P≤0.001) 
increase in TL time when compared with control group. Hydro-
methanolic extract of TPLC F1, TPLC F2, TPLC F3 (100 mg/kg p. o.) 
and standard (Vitamin E, Rivastigmine) significantly (P≤0.001) 
reduce TL time when compared to STZ treated group. The effect of 
TPLC F2 (100 mg/kg p. o.) was noticed to be comparable to standard 
(Vitamin E) treated group (fig. 5).  
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Biochemical estimation  
Effect of Triphala Churana fruits extract on brain AchE activity 
of streptozotocin (i. c. v.) treated rats 
Treatment with streptozotocin showed significant (P≤0.001) 
increase in brain AchE activity when compared to control group. The 
rats were treated with Vitamin E and Rivastigmine showed 
significant (P≤0.001) decrease in AchE activity when compared to 
streptozotocin treated group, whereas a significant (P≤0.01) 
decrease in AchE activity was observed in the TPLC F3 and TPLC F2 
treated group. TPLC F1 group showed low significance at P≤0.05 
while compared to the STZ treated group (fig. 6). 
Effect of Triphala Churana fruits extract on lipid peroxidation of 
streptozotocin (i. c. v.) treated rats 
Lipid peroxidation study showed that streptozotocin treated group 
showed significant (P≤0.001) increase in MDA level when compared 
to control group. Standard (Vitamin E and Rivastigmine) and TPLC 
F2, TPLC F3 treated group were able to prevent the elevated MDA 
level, showed significant at (P≤0.001) and TPLC F1 showed 
significance at (P≤0.01) decrease in MDA level when compared to 
streptozotocin treated group (fig. 7). 
Effect of Triphala Churna fruits extract on level of glutathione 
streptozotocin treared rats  
Streptozotocine treated group showed significant (P≤0.001) 
decrease in glutathione level when compared with control group. 
Whereas, standard (Vitamin E and Rivastigmine) treated showed 
significant (P≤0.001) increase in activity of glutathione when 
compared to streptozotocin treated group. In another hand TPLC F1, 
TPLC F2 treated group showed significant (P≤0.001) increase in 
glutathione level when compared to STZ group but results are not 
better than the standard treated group. TPLC F1 showed low 
significance (P≤0.01) when compared to STZ group (fig. 8). 
Effect of Triphala Churna fruits extract on level of SOD 
streptozotocin-treated rats  
Streptozotocin-treated group showed significant (P≤0.001) decrease 
in SOD level when compared with control group. Whereas, standard 
(Vitamin E and Rivastigmine) treated showed significant (P≤0.001) 
increase in activity of SOD level when compared to streptozotocin 
treated group. In another hand TPLC F2 and TPLC F3 treated group 
showed significant (P≤0.001, P≤0.01) increase in SOD level when 
compared to the standard treated group but results are not better 
than standard treated group (fig. 9). 
 
 
Fig. 1: Effect of STZ (i. c. v) on escape latency time (ELT) during acquisition trials on morris water maze in rats. Each group (n=6) 
represents mean±standard error of means (SEM), a= p≤ 0.001 Vs. ELT on the first day of the control group, b= p≤ 0.001 Vs. ELT on the 
same day of the control group. STZ-Streptozotocin 
 
 
Fig. 2: Effect of STZ (i. c. v) on time spent in the target quadrant (TSTQ) during retrieval trial on morris water maze in rats. Each group 
(n=6) represents mean±standard error of means (SEM), a= p≤ 0.001 vs. time spent in another quadrant in STZ treated group, b=p≤0.001 
vs. time spent in the target quadrant (Q4) of STZ treated group. STZ-Streptozotocin 
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Fig. 3: Effect of Triphala Churna fruits extract on escape latency of streptozotocin-treated rats on morris water maze (1-4 d) in sec. Each 
group (n=6) represents mean±standard error of means (SEM), a= p≤ 0.001 vs. ELT on the first day of STZ (i. c. v) treated group, b=p≤0.001 












































































Fig. 4: Effect of Triphala Churna fruits extract on time spent in target quadrant (TSTQ) during retrieval trial in STZ treated rats on morris 
water maze. Each group (n=6) represents mean±standard error of means (SEM). a= p≤ 0.001 vs. time spent in another quadrant in STZ 
treated group, b=p≤0.001 vs. time spent in target quadrant (Q4) of STZ treated group. STZ-Streptozotocin, TPLC-Triphala Churna, F1-
Formulation 1, F2-Formulation 2, F3-Formulation 3 
 
 
Fig. 5: Effect of Triphala Churna fruits extract on transfer latency (TL) of streptozotocin-treated rats on elevated plus maze (acquisition 
and retrieval in sec±SEM). Each group (n=6) represents mean±standard error of means (SEM), a= P≤0.001 Vs control group, b=P≤0.001 Vs 
STZ treated group. STZ-Streptozotocin, TPLC-Triphala Churna, F1-Formulation 1, F2-Formulation 2, F3-Formulation 3 
Deka et al. 




Fig. 6: Effect of Triphala Churna fruits extract on brain cholinesterase activity in streptozotocin-treated rats. Each group (n=6) represents 
mean±standard error of means (SEM), a= P≤0.001 versus control group, b= P≤0.001 versus STZ treated group, c=P≤0.01 versus STZ 




Fig. 7: Effect of Triphala Churna fruits extract on lipid peroxidation in streptozotocin-treated rat’s brain. Each group (n=6) represents 
mean±standard error of means (SEM), a= P≤0.001 versus control group, b=P≤0.001 versus STZ treated group, c=P≤0.01 versus STZ 
treated group. STZ-Streptozotocin, TPLC-Triphala Churna, F1-Formulation 1, F2-Formulation 2, F3-Formulation 3 
 
 
Fig. 8: Effect of Triphala Churna fruits extract on the level of glutathione in streptozotocin-treated rat’s brain. Each group (n=6) 
represents mean±standard error of means (SEM), a=P≤0.001 versus control group, b=P≤0.001 versus STZ treated group, c= P≤0.01 versus 
STZ treated group. STZ-Streptozotocin, TPLC-Triphala Churna, F1-Formulation 1, F2-Formulation 2, F3-Formulation 3 
Deka et al. 




Fig. 9: Effect of Triphala Churna fruits extract on level of superoxide dismutase in streptozotocin-treated rat’s brain. Each group (n=6) 
represents mean±standard error of means (SEM), a=P≤0.001 versus control group, b=P≤0.001 versus STZ treated group, c=P≤0.01 versus 
STZ treated group. STZ-Streptozotocin, TPLC-Triphala Churna, F1-Formulation 1, F2-Formulation 2, F3-Formulation 3 
 
DISCUSSION 
Dementia is an umbrella term that encompasses symptoms of a 
chronic progressive cognitive decline usually affecting memory and 
almost always a judgment, decision-making, and relationships with 
others. Dementia can be divided into cortical and subcortical forms. 
Alzheimer’s disease is a form of cortical dementia, as is creutzfeldt-
Jakob disease (CJD). In subcortical dementia, structures below the 
cerebral cortex are affected or damaged, such as occurs in 
Parkinson’s disease. In multi-infarct dementia both the cortical and 
subcortical parts of the brain are affected. Dementia can also be 
divided into reversible causes such as hypothyroidism, normal 
pressure hydrocephalus, and vitamin B12 deficiency, and 
irreversible causes such as alzheimer’s disease. The most common 
causes of progressive dementia are alzheimer’s disease, vascular 
dementia, and dementia with lewy bodies, frontotemporal dementia, 
parkinson ’s disease, and wernicke-korsakoff dementia. Alzheimer’s 
disease (AD) is a neurodegenerative disease which involves 
progressive and irreversible loss of neurons in various regions of the 
brain. It constitutes approximately 60% of all cases of dementia and 
is more common in women. It is characterized by impairment of 
memory and at least one cognitive domain (aphasia, apraxia, 
agnosia, executive function) [24, 25]. Dementia is one of the 
characteristics of Alzheimer’s disease, Donepezil and Galantamine 
are the established drugs to treat dementia associated with 
Alzheimer’s disease [33]. 
Oxidative stress, which occurs when there is an imbalance between 
antioxidants and reactive oxygen species within a cell, may lead to 
permanent cellular damage. The polyunsaturated fatty acids of 
membrane lipids are prime targets for reactive oxygen species and 
peroxide radicals. The central nervous system is particularly 
vulnerable to lipid peroxidation because of its high lipid content and 
unusually high proportion of polyunsaturated fatty acids. In AD 
patients, concentrations of malondialdehyde, a measure of lipid 
peroxidation, are elevated. Lipid peroxidation may promote the 
formation of additional reactive oxygen species and enhance protein 
and DNA oxidative damage.  
Vitamin E has an excellent safety record [32]. Vitamin E is a 
necessary nutrient in human body and it is a popular antioxidant 
substance. It decreases reactive oxygen species activity and free 
radicals like other antioxidants. Vitamin E prevents or delays 
memory impairments that accompany many conditions such as 
cerebral ischemic injury, mental stress, aging, diabetes, alzheimer’s 
disease, stroke etc [29]. 
Rivastigmine is a carbamate-based, reversible, non-competitive 
inhibitor of both AChE and butyrylcholinesterase. Its inhibitory 
effect is of long duration and is relatively specific to the central 
nervous system. Rivastigmine is approved for the mild-to-moderate 
AD and for mild-to-moderate dementia related to Parkinson's 
disease [30]. Rivastigmine provides a distinct benefit for AD, and PD, 
patients with dementia [31]. 
Streptozotocin significantly impaired the learning and memory, after 
the administration of streptozotocin on 1stand3rdday. ICV-STZ 
treatment causes a marked reduction in brain glucose/energy 
metabolism and shows a progressive trend towards oxidative stress. 
ICV-STZ generated NMDA receptor overactivation, mitochondrial 
dysfunction, decrease neuronal glucose which causes a decrease in 
Ach, ChAT, ATP and increase in AchE etc. These lead to oxidative 
damage, DNA damage, neuroinflammation after that it causes 
learning and memory impairment and neurotoxicity. 
Morris water maze test and elevated plus maze are employed as 
most extensively accepted model for evaluation of learning and 
memory. Rats were taken lesser seconds in transfer latency 
(retrieval) as compared to transfer latency (acquisition) it means 
standard and Triphala Churna showed better result in retrieval day. 
In Morris water maze, after the administration of standard and 
Triphala Churna significant reduction in escape latency time and 
also increase time spent in target quadrant on 5th d. 
The AchE elevated level in alzheimer’s disease has results in the 
hypothesis that learning and memory impairment is linked to 
cholinergic degradation. Therefore precise approach for treatment 
of alzheimer’s disease is to increase Ach level in the brain region. 
The present study shows that a significant increase in AchE in 
streptozotocin administered rats. A significant decrease AchE function 
has been showed in the rats treated with Triphala Churna especially in 
Triphla Churna Formulation2 (100 mg/kg/day p. o.) dose. 
Excessive synthesis of free radicals or the reactive oxygen species 
can lead to the damage of the cell and tissue of the brain which leads 
to cell death. The classes of main defense antioxidant that prevent 
the generation of new free radical species are glutathione and SOD. 
The further study concluded that the oxidative stress is induced by 
streptozotocin (i. c. v.) on 1st and 3rdday. In rats streptozotocin 
decrease the SOD and glutathione level. After the administration of 
Vitamin E, Rivastigmine and Triphala Churna showed a significant 
increase in SOD and glutathione level. 
An elevated level of lipid peroxidation in the brain shows the neuronal 
damage. The decrease of antioxidant defense and increase in free 
radical generation deteriorates the pro-oxidant and antioxidant 
balance regulation which leads to oxidative stress and cell death. 
The oxidative stress produced by streptozotocin has been linked 
with the increased amount of lipid peroxidation. The administration 
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of a hydro-methanolic extract of Triphala Churna in my experiment 
was potentially active in reducing the oxidative stress. This indicates 
that Triphala Churna fruits extract has a potent antioxidant activity 
to reduce the oxidative stress induced lipid peroxidation. Triphal 
Churna Formulation2 (100 mg/kg/d p. o.) showed more 
improvement in dementia comparison to the other test groups. 
CONCLUSION 
The aim of the present study was to evaluate the pharmacological 
effect of Triphala Churna on streptozotocin-induced dementia in 
rats. This was proved by the following parameters. 
The phytochemical constituents in Triphala Churna are phenolic 
acids, flavonoids, tannins etc. It contains gallic acid, tannic acid, 
syringic acid, epicatechin, ascorbic acid, aellagitann,interchebulin 
along with punicalagin, terflavin-A, shikimic, tricontanoic, palmitic 
acids, beta-sitosterol, daucosterol, triterpene chebupentol etc. 
Disease induced STZ (i. c. v.) treated rats shows a significant increase 
in the AchE activity. Whereas, this increased activity is reverse by 
treatment of group with Triphala Churna and standard (Vitamin E, 
Rivastigmine). Reduction in the AchE activity by Triphala Churna 
fruits extract may directly or indirectly related to the cholinergic 
dependent learning and memory. 
After administration of STZ (i. c. v), disease control rats showed a 
decrease in free radical scavenging enzymes such as SOD and 
glutathione. In another hand after the administration of TPLC, free 
radical scavenging enzyme restored significantly. 
In present study treatment by TPLC decreases the lipid peroxidation. 
Hence, it was concluded the Triphala Churna have a potential role in 
the management of learning and memory impairment. 
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